TRT and Sleep Apnea: Understanding Risks & Management

Last Updated: OCTOBER 2023

Obstructive Sleep Apnea (OSA) is a serious condition, with men suffering from severe OSA experiencing a 3-fold higher risk of all-cause mortality compared to those without the disorder (Sleep, 2017). The relationship between testosterone and OSA is complex, often presenting a Catch-22: low testosterone levels are frequently associated with OSA, yet Testosterone Replacement Therapy (TRT) can, in some cases, worsen or unmask existing sleep-disordered breathing. Understanding this dynamic is crucial for safe and effective TRT.

The Interplay of Low Testosterone and OSA

An inverse relationship exists between male serum testosterone levels and the prevalence or severity of obstructive sleep apnea. Men with lower testosterone frequently experience higher rates of OSA. This connection is not merely coincidental. Low testosterone can contribute to changes in body composition, specifically increased adiposity, which is a major risk factor for OSA. It can also influence upper airway muscle tone, potentially leading to increased collapsibility during sleep. Research published in the American Journal of Managed Care (AJMC) highlights this inverse correlation, underscoring that men with OSA often present with sub-optimal testosterone levels, sometimes falling below the outdated clinical threshold of 264 ng/dL. This historical lower bound, established from a population including sick and elderly men in the 1970s, often fails to identify men who are symptomatic and would benefit from TRT, regardless of co-existing OSA. The physiological impact of OSA, including chronic hypoxia and sleep fragmentation, can also suppress the hypothalamic-pituitary-gonadal axis, further contributing to low testosterone.

How TRT Can Impact Sleep Apnea

While TRT effectively alleviates symptoms of hypogonadism, it can sometimes exacerbate or unmask pre-existing, undiagnosed OSA. It is less common for TRT to induce de novo OSA in individuals without any prior predisposition, but the potential for worsening existing conditions is significant. Several mechanisms are proposed for this effect:

• Increased Erythropoiesis: Testosterone stimulates red blood cell production. Higher hematocrit, while generally manageable with therapeutic phlebotomy or dose adjustment on TRT, can increase blood viscosity. This thicker blood may strain the cardiovascular system and potentially affect central respiratory drive, although this link to OSA worsening is indirect. Consistent CPAP therapy, when indicated for OSA, frequently reduces hematocrit meaningfully in men on TRT.
• Central Nervous System Effects: Testosterone can influence the brain’s respiratory control centers. While the exact mechanisms are not fully elucidated, some theories suggest testosterone might alter ventilatory responses to hypoxia and hypercapnia, or change sleep architecture, potentially leading to more unstable breathing patterns during sleep.
• Fluid Retention: TRT can sometimes lead to increased fluid retention, particularly with higher doses or less frequent injections. This fluid can accumulate in the neck and pharyngeal tissues, narrowing the airway and increasing the likelihood of collapse during sleep.
• Changes in Upper Airway Musculature: While testosterone generally improves muscle mass, its specific effect on the pharyngeal muscles and their tone during sleep is complex and may vary. Some research suggests testosterone can increase upper airway collapsibility in some individuals.

Testosterone esters such as testosterone cypionate and enanthate, commonly used in TRT, deliver stable levels of testosterone but can have a peak effect that might be associated with transient fluid retention or other changes if not administered frequently enough.

Screening and Diagnosis for OSA on TRT

Before initiating TRT, and throughout therapy, vigilance for OSA symptoms is paramount. Providers committed to patient autonomy and comprehensive care recognize the importance of screening. Key indicators for OSA that warrant investigation include:

• Loud, chronic snoring
• Observed pauses in breathing during sleep
• Daytime sleepiness or fatigue, even after a full night’s rest
• Morning headaches
• Difficulty concentrating or memory problems
• Irritability or mood changes
• Nocturia (frequent nighttime urination)
• High hematocrit levels, especially if rising consistently on TRT without other clear causes.

A formal sleep study (polysomnography, PSG) conducted in a sleep lab, or a home sleep apnea test (HSAT), remains the gold standard for diagnosing OSA. For men with suggestive symptoms, or those at high risk (e.g., obesity, large neck circumference, family history of OSA), screening prior to or early in TRT is a responsible approach. This ensures that any sleep-disordered breathing is identified and addressed, optimizing overall health outcomes and TRT efficacy.

Managing OSA While on TRT

Managing OSA effectively while on TRT requires a multi-faceted approach. The primary goal is to treat the sleep apnea itself, which often involves lifestyle changes and medical devices.

Cornerstone Therapy: CPAP

Continuous Positive Airway Pressure (CPAP) therapy is the most effective and widely recognized treatment for moderate to severe OSA. It works by delivering a continuous stream of air through a mask worn during sleep, keeping the airway open. As stated in a review in ScienceDirect, “CPAP remains the cornerstone for managing OSA, but its inconsistent impact on testosterone levels underscores the need for complementary interventions.” Consistent CPAP use not only improves sleep quality and reduces cardiovascular risk but can also meaningfully lower elevated hematocrit levels often seen in men with OSA, whether they are on TRT or not.

Lifestyle Interventions

• Weight Management: Losing even a moderate amount of weight can significantly reduce OSA severity, especially if obesity is a contributing factor.
• Positional Therapy: Sleeping on one’s side rather than on the back can alleviate airway collapse in some individuals.
• Avoid Alcohol and Sedatives: These substances relax throat muscles, worsening OSA.
• Smoking Cessation: Smoking irritates the airway, contributing to inflammation and narrowing.

TRT Protocol Adjustments

For men with existing or newly diagnosed OSA, adjustments to the TRT protocol can be considered, always in conjunction with direct OSA treatment. The aim is to achieve optimal testosterone levels (e.g., total testosterone 600–900 ng/dL, free testosterone 15–25 pg/mL) while minimizing any potential exacerbating factors.

• Dose Modulation: Lowering the testosterone dose slightly, for example, to 80–120mg testosterone cypionate or enanthate per week, may reduce potential fluid retention and erythrocytosis, without sacrificing therapeutic benefits for many men.
• Increased Injection Frequency: Administering testosterone more frequently (e.g., 2–3 times per week) can help maintain more stable testosterone levels, avoiding high peaks and low troughs. This may mitigate some side effects.
• HCG Considerations: For men who wish to maintain testicular function or reduce the overall exogenous testosterone load, Human Chorionic Gonadotropin (HCG) can be incorporated